Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2006

01.04.2006 | Original Paper

Clinical significance of a wide excision policy for sacrococcygeal chordoma

verfasst von: Shunzo Osaka, Osamu Kodoh, Hideyuki Sugita, Eiji Osaka, Yoshiyuki Yoshida, Junnosuke Ryu

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

Purpose: Surgical treatment of sacrococcygeal chordoma is very difficult and the recurrence rate is high. We investigated the outcomes of wide excision in 12 sacrococcygeal chordoma patients treated between 1983 and 2003. Methods: The 12 patients underwent primary wide excision. The conventional procedure was wide excision employing a chisel and airtome for sacral tumours, and in 1997 a new threadwire saw procedure was introduced. All 12 patients were included in a retrospective analysis of tumour- and treatment-related variables, and outcomes. Results: Six patients underwent surgery with a combined anterior–posterior approach at the cephalad sacral border. In 12 patients, 11 lesions were broadly excised, and in the 1 remaining patient the intralesional margin showed tumour contamination due to a fracture macroscopically. The latter patient received post-operative radiation therapy, but suffered a recurrence 8.0 years later. Three patients died before final follow-up: one from subsequent metastases, two elderly patients from complications. For the 10 chordoma patients, i.e. excluding the two who died due to complications, the 5, 10 and 20 years recurrence rates were 100, 66.7 and 66.7%, respectively. For the 12 patients, overall 5, 10 and 20 years survival rates were 83.3, 55.6 and 55.6%, respectively. Conclusions: Our results suggest that large chordoma should be widely excised, using a modified threadwire saw, with a combination of anterior–posterior procedures.
Literatur
Zurück zum Zitat Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V et al (1988) Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 37:185–191PubMedCrossRef Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V et al (1988) Chordoma: natural history and treatment results in 33 cases. J Surg Oncol 37:185–191PubMedCrossRef
Zurück zum Zitat Baratti D, Gronch A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 10:291–296PubMedCrossRef Baratti D, Gronch A, Pennacchioli E, Lozza L, Colecchia M, Fiore M, Santinami M (2003) Chordoma: natural history and results in 28 patients treated at a single institution. Ann Surg Oncol 10:291–296PubMedCrossRef
Zurück zum Zitat Fourney DR, Gokaslan ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15:1–4CrossRef Fourney DR, Gokaslan ZL (2003) Current management of sacral chordoma. Neurosurg Focus 15:1–4CrossRef
Zurück zum Zitat Furukawa H, Yamamoto Y, Igawa HH, Sugihara T (2000) Gluteus maximus adipomuscular turnover or sliding flap in the surgical treatment of extensive sacral chordomas. Plast Reconstr Surg 105:1013–1016PubMedCrossRef Furukawa H, Yamamoto Y, Igawa HH, Sugihara T (2000) Gluteus maximus adipomuscular turnover or sliding flap in the surgical treatment of extensive sacral chordomas. Plast Reconstr Surg 105:1013–1016PubMedCrossRef
Zurück zum Zitat Gennari L, Azzarelli A, Quagliuolo V (1987) A posterior approach for the excision of sacral chordoma. J Bone Joint Surg [Br] 69:565–568 Gennari L, Azzarelli A, Quagliuolo V (1987) A posterior approach for the excision of sacral chordoma. J Bone Joint Surg [Br] 69:565–568
Zurück zum Zitat Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyamoto T, Kato S, Kandatsu S, Mizoe JE, Tsujii H, Tatezaki S (2004) Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 10:5741–5746PubMedCrossRef Imai R, Kamada T, Tsuji H, Yanagi T, Baba M, Miyamoto T, Kato S, Kandatsu S, Mizoe JE, Tsujii H, Tatezaki S (2004) Carbon ion radiotherapy for unresectable sacral chordomas. Clin Cancer Res 10:5741–5746PubMedCrossRef
Zurück zum Zitat Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y (2002) Local recurrence after S2–3 sacrectomy in sacral chordoma, report of four cases. J Neurosurg Spine 97:98–101CrossRef Ishii K, Chiba K, Watanabe M, Yabe H, Fujimura Y, Toyama Y (2002) Local recurrence after S2–3 sacrectomy in sacral chordoma, report of four cases. J Neurosurg Spine 97:98–101CrossRef
Zurück zum Zitat Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481CrossRef
Zurück zum Zitat Koh PK, Tan BK, Hong SW, Tan MH, Tay AG, Song C, Tan KC (2004) The gluteus maximus muscle flap for reconstruction of sacral chordoma defect. Ann Plast Surg 53:44–49PubMedCrossRef Koh PK, Tan BK, Hong SW, Tan MH, Tay AG, Song C, Tan KC (2004) The gluteus maximus muscle flap for reconstruction of sacral chordoma defect. Ann Plast Surg 53:44–49PubMedCrossRef
Zurück zum Zitat Morikawa K, Osaka S, Shiraishi M, Toriyama S, Sato H, Sawada T (1992) Chordoma with a massive spindle-cell sarcomatous transformation: a case report (in Japanese). J Kanto Orthop Traumatol Assoc 23:295–298 Morikawa K, Osaka S, Shiraishi M, Toriyama S, Sato H, Sawada T (1992) Chordoma with a massive spindle-cell sarcomatous transformation: a case report (in Japanese). J Kanto Orthop Traumatol Assoc 23:295–298
Zurück zum Zitat Osaka S, Toriyama S (1989) Treatment and prognosis of sacrococcygeal chordoma—study of bone tumour registry in Japan (in Japanese with English abstract). J Jpn Orthop Assoc 63:240–244 Osaka S, Toriyama S (1989) Treatment and prognosis of sacrococcygeal chordoma—study of bone tumour registry in Japan (in Japanese with English abstract). J Jpn Orthop Assoc 63:240–244
Zurück zum Zitat Osaka S, Taira K, Yoshida Y, Sakurada E, Toriyama M (1997) Excision techniques for sacral chordoma: a case report. J Orthop Surg 5:121–123 Osaka S, Taira K, Yoshida Y, Sakurada E, Toriyama M (1997) Excision techniques for sacral chordoma: a case report. J Orthop Surg 5:121–123
Zurück zum Zitat Osaka S, Kondoh O, Yoshida Y, Ryu J (2005) Radical excision of malignant sacral tumours using a threadwire saw. J Surg Oncol (in press) Osaka S, Kondoh O, Yoshida Y, Ryu J (2005) Radical excision of malignant sacral tumours using a threadwire saw. J Surg Oncol (in press)
Zurück zum Zitat Samson IR, Springfield DS, Suit HD, Mankin HJ (1993) Operative treatment of sacrococcygeal chordoma. J Bone Joint Surg [Am] 75:1476–1485 Samson IR, Springfield DS, Suit HD, Mankin HJ (1993) Operative treatment of sacrococcygeal chordoma. J Bone Joint Surg [Am] 75:1476–1485
Zurück zum Zitat Schulz-Erthner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger CP et al (2003) Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull. Results in 67 patients. Strahlenther Onkol 179:598–605CrossRef Schulz-Erthner D, Nikoghosyan A, Thilmann C, Haberer T, Jäkel O, Karger CP et al (2003) Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull. Results in 67 patients. Strahlenther Onkol 179:598–605CrossRef
Zurück zum Zitat Stener B, Gunterberg B (1978) High amputation of the sacrum for extirpation of tumours. Principles and techniques. Spine 3:351–366PubMedCrossRef Stener B, Gunterberg B (1978) High amputation of the sacrum for extirpation of tumours. Principles and techniques. Spine 3:351–366PubMedCrossRef
Zurück zum Zitat Tomita K, Kawahara N (1996) The threadwire saw: a new device for cutting bone. J Bone Joint Surg [Am] 78-A:1915–1917 Tomita K, Kawahara N (1996) The threadwire saw: a new device for cutting bone. J Bone Joint Surg [Am] 78-A:1915–1917
Zurück zum Zitat Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H (1999) The surgical treatment of sacrococcygeal chordoma. Cancer 85:878–888PubMedCrossRef Yonemoto T, Tatezaki S, Takenouchi T, Ishii T, Satoh T, Moriya H (1999) The surgical treatment of sacrococcygeal chordoma. Cancer 85:878–888PubMedCrossRef
Metadaten
Titel
Clinical significance of a wide excision policy for sacrococcygeal chordoma
verfasst von
Shunzo Osaka
Osamu Kodoh
Hideyuki Sugita
Eiji Osaka
Yoshiyuki Yoshida
Junnosuke Ryu
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2006
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-005-0067-3

Weitere Artikel der Ausgabe 4/2006

Journal of Cancer Research and Clinical Oncology 4/2006 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.